Package 65841-836-10

{"route": ["ORAL"], "spl_id": "6c831525-a7c2-4ef1-b1b9-c7e8cb807ded", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["78d34aad-9d4f-48c4-91eb-536e31c6b6c9"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-05)", "package_ndc": "65841-836-05", "marketing_start_date": "20180802"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-06)", "package_ndc": "65841-836-06", "marketing_start_date": "20180802"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-10)", "package_ndc": "65841-836-10", "marketing_start_date": "20180802"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-16)", "package_ndc": "65841-836-16", "marketing_start_date": "20180802"}], "brand_name": "bupropion", "product_id": "65841-836_6c831525-a7c2-4ef1-b1b9-c7e8cb807ded", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "65841-836", "generic_name": "bupropion", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA201567", "marketing_category": "ANDA", "marketing_start_date": "20180802", "listing_expiration_date": "20261231"}